International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-6 doi: 10.5281/zenodo.10448124
Original Article
Correlation between Dha (Docosahexaenoic Acid) Supplementations and Sod (Superoxide Dismutase) On Underweight Pregnant
 ,
 ,
Published
Dec. 31, 2023
Abstract

Background: In 2018, Basic Health Research (RISKESDAS) reported that East Java was one of the provinces in Indonesia with a prevalence of chronic energy deficiency (CED) in women of childbearing age above the national prevalence (19.6%). Chronic Energy Deficiency (CED) is a nutritional problem that can occur in pregnant women due to inadequate energy and protein intake and needs. Chronic Energy Deficiency (CED) is characterized by a pregnant woman's Mid Upper Arm Circumference (MUAC), which is less than 23.5 cm. Nutritional problems and weight loss in pregnant women can cause a decrease in body resistance, and pregnant women become increasingly susceptible to oxidative stress. This research focuses on examining the correlation between the antioxidant SOD and the administration of DHA to underweight pregnant women.

Methods: The research was conducted using an experimental pre and post-test with 21 samples of underweight pregnant women at Made Community Health Center, Surabaya.

Results: Body weight (P < 0,001); Height (P = 0, 88); BMI (P = 0,003); MUAC (P = 0,003); Systolic BP (P = 0,111); Diastolic BP (P = 0,887); Fundal Height (P = 0,001); SOD (P = 0,013).

Conclusions: In this study, a correlation was found between the supplementation of DHA and the weight, BMI, MUAC, fundal height, and SOD levels in underweight pregnant women.

Recommended Articles
Loading Image...
Volume-4, Issue-6
Citations
2987 Views
273 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved